Condition
Mitral Valve Annuloplasty
Total Trials
3
Recruiting
0
Active
0
Completed
1
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 55/100
Termination Rate
33.3%
1 terminated out of 3 trials
Success Rate
50.0%
-36.5% vs benchmark
Late-Stage Pipeline
33%
1 trials in Phase 3/4
Results Transparency
100%
1 of 1 completed with results
Key Signals
1 with results50% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 3 (1)
Trial Status
Terminated1
Not Yet Recruiting1
Completed1
Trial Success Rate
50.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT07434661Phase 3Not Yet Recruiting
Apixaban VS Warfarin in AF Pts First Three Months After Repair or BIO AVR MVR
NCT06408779Completed
Study on Surgical Treatment Strategies for Moderate Ischemic Mitral Regurgitation
NCT02703311Not ApplicableTerminated
REPAIR - transcatheteR rEPair of mitrAl Insufficiency With caRdioband System
Showing all 3 trials